Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patients' lives, and lead to a cure.
Being tested for multiple myeloma can be stressful, and knowing what to expect can help.
Here's a simple guide to the tests, what comes next, and why waiting for results is a normal part of the process.
Caring for someone through multiple myeloma takes strength, patience, and love. This National Family Caregivers Month, we want to honor that. Caregivers, we'd love to hear from you. What has caregiving taught you?
The Corvette Club of Western Massachusetts turned their “All Makes and Models” car show into something bigger, raising over $8,000 for the MMRF and myeloma research.
A shared love of cars, driving real impact for patients.
Read more: https://t.co/3pZ75VB4rQ
Diagnosed with myeloma nearly 20 years ago and now in remission, Tom and his wife Mary have made the MMRF part of their legacy.
Read their story: https://t.co/S0Sj0mWTGQ
Anyone can develop multiple myeloma, but some factors raise the risk, including age, family history, and race.
Knowing your risk helps you and your care team decide whether to keep an eye on things, though most with risk factors never develop myeloma.
https://t.co/79HnxLE6t7
Join the MMRF and University of Miami for a free Myeloma Patient Summit.
Spend the evening with leading experts covering the latest on myeloma, from biology to treatment to supportive care.
Thurs, Nov 5 | 4-8PM ET
In person in Miami or virtually
Register: https://t.co/j2gn7JqzfR
On #NationalCatDay, your litter purchase can help fund a cure for multiple myeloma.
Now through March, save $3 on a 40 lb bag of Dr. Elsey’s Ultra or Cat Attract litter, and they’ll donate $3 to the MMRF.
Download your coupon: https://t.co/vliWMQ1cWy
#Save3#MMRF
Meet Jessie, one of our MMRF Myeloma Mentors. Diagnosed with smoldering myeloma a decade ago, she now helps others navigate that same gray-area diagnosis with perspective and hope.
Connect with Jessie: https://t.co/25BcKj384D
MRD (minimal residual disease) testing can detect as few as 1 myeloma cell among 1 million. Here's a simple break-down guide to what your results mean.
Read more: https://t.co/2qRU73MFjy
Curious about clinical trials and what they could mean for you?
Join a free MMRF webinar where myeloma experts explain what trials are, what to expect, and how to decide if one is right for you.
📅 Wed, Oct 28 | 4PM ET
Register: https://t.co/8tQvsiSePY.
Your experience with multiple myeloma could help someone just starting theirs. Our partners at @curetoday are inviting patients, survivors and caregivers to share their stories. Submit yours: https://t.co/aHHbK1D2Or
Since 2011, Andy’s Angels have walked the MMRF Chicago Walk every year, in honor of Andrea Rosengarden, who passed from myeloma in 2020.
This year, we’re honoring the team with the Spirit of Hope Award.
Read their story: https://t.co/xtEaeUR0Po
Join us and @UCSFHospitals for a free Myeloma Patient Summit.
Spend the morning with leading experts covering the latest on myeloma, from biology to treatment to supportive care.
📅 Sat, Oct 24 | 8AM-12:30PM PT
📍In person in SF or virtually
Register: https://t.co/H6ksnmaWHq
Moving #MultipleMyeloma treatment into the community requires consideration of care coordination, monitoring, and toxicity management.
Learn more in the latest Multiple Myeloma Hub masterclass: https://t.co/xb1mnyFgvq
#myeloma#mmsm
🎥 How can bispecific antibody therapy be delivered across outpatient and community settings in #MultipleMyeloma?
Shaji Kumar, Rakesh Popat, and María-Victoria Mateos discuss transitioning patients to community-based care, outpatient treatment delivery, and toxicity management.
Explore the masterclass series here: https://t.co/yR0QrdGVMI
#myeloma #mmsm #MedEd @myelomaMD@DrRakeshPopat@mvmateos
Just diagnosed with multiple myeloma? These 4 steps can help you move forward: build your team, get the right tests, find the right treatment, and connect with your community.
Read more: https://t.co/IpKOmRCEri
The program provides funding, mentorship, and career development opportunities for promising clinical and laboratory investigators whose experiences and connections help reflect the communities most impacted by multiple myeloma.